ApprovalTrail

Approval · Notice of Compliance 1719 · 2003

ATIVAN: Notice of Compliance 1719

Issued April 2, 2003

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
1719
Date
April 2, 2003
Company
Wyeth CanadaSt. Laurent, Quebec, Canada
Product type
Prescription Pharmaceutical
Submission
New Drug Submission (NDS)
Submission class
Admin
Reason
Manufacturer name change
Therapeutic class
Anxiolytic, sedative

Products in this notice

BrandDINStatus today
ATIVAN02041421Cancelled Post Market
ATIVAN02041448Cancelled Post Market
ATIVAN02041456Cancelled Post Market
ATIVAN02041464Cancelled Post Market
ATIVAN02041472Cancelled Post Market
ATIVAN02041413Cancelled Post Market
ATIVAN02041405Cancelled Post Market

Medicinal ingredients